XML 67 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
(11) Common Stock and Common Stock Equivalents
12 Months Ended
Jun. 30, 2014
Notes  
(11) Common Stock and Common Stock Equivalents

(11)  Common Stock and Common Stock Equivalents

On July 15, 2003, the board of directors (board) approved an open-market share repurchase program for up to $500,000 of the Company’s common stock. On November 27, 2007, the board approved an additional $250,000 for the open-market share repurchase program after the original $500,000 was used. In February 2011, the board approved an additional $1,000,000 for repurchases under the program. During fiscal year 2010, the board authorized the repurchase of up to $100,000 of stock annually for three years from each of two former distributors that were acquired by the Company in 2007. During the year ended June 30, 2014, the Company did not acquire any shares of common stock. During the year ended June 30, 2013, the Company acquired and retired 32,786 shares of common stock for $99,997.

During the years ended June 30, 2014 and 2013, the Company granted 1,485 and 13,689 shares, respectively, of restricted common stock to directors and officers in connection with compensation arrangements.

The Company maintains a 2005 equity incentive plan for the benefit of employees.  Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plan.  Awards granted under the plan may be performance-based. Effective November 27, 2007, the plan was amended, as approved by the shareholders, to increase the number of shares available by 1,000,000 shares. As of June 30, 2014, 117,451 shares of common stock were authorized and reserved for issuance, but were not granted under the terms of the 2005 equity incentive plan as amended.

The Company granted options to acquire common stock under its 2005 equity incentive plan during fiscal years 2014 and 2013. The options are granted at not less than 100% of the market price of the stock at the date of grant. Option terms are determined by the board, and exercise dates may range from 6 months to 10 years from the date of grant.

The fair value of each option grant was estimated on the date of grant using the Black Scholes option pricing model with the following assumptions:

 

 

 

 

 

 

 

 

2014

 

2013

Expected dividend yield

 

0%

 

0%

Expected stock price volatility

 

69%

 

69%

Risk-free interest rate

 

2.53%

 

1.74%

Expected life of options

 

 10 years

 

10 years

 

The weighted average fair value of options granted during fiscal years 2014 and 2013 was $1.89 and $2.03, respectively.

The following table summarizes the Company’s stock option activity during the reported fiscal years:

 

 

 

 

 

 

 

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

average

 

 

Weighted

 

 

 

 

 

 

 

 

Number

 

average

remaining

Number

 

average

 

 

 

 

 

 

 

 

of

 

exercise

contractual

of

 

exercise

 

 

 

 

 

 

 

 

shares

 

price

term

shares

 

price

Options outstanding at

 

 

 

 

 

 

 

 

 

beginning of the year

 

163,868

$

6.51 

4.12 years

173,089

$

6.48 

Options granted

 

3,598

 

2.42

 

1,352

 

2.70

Options exercised

 

       -

 

    -

 

(208)

 

    1.75

Options canceled or expired

 

(11,862)

 

6.01

 

(10,365)

 

5.69

Options outstanding at end

 

 

 

 

 

 

 

 

 

of the year

 

155,604

 

6.45

3.56 years

163,868

 

6.51

Options exercisable at end

 

 

 

 

 

 

 

 

 

of the year

 

137,804

 

7.09

 

138,920

 

7.20

Range of exercise prices at

 

 

 

 

 

 

 

 

 

end of the year

 

 

$

1.75 – 8.60

 

 

$

1.75 – 8.60

 

The Company recognized $70,871 and $86,639 in stock-based compensation for the years ended June 30, 2014 and 2013, respectively, which is included in selling, general, and administrative expenses in the consolidated statements of operations. The stock-based compensation includes amounts for both restricted stock and stock options under ASC 718.

As of June 30, 2014 there was $387,855 of unrecognized stock-based compensation cost that is expected to be expensed over periods of four to nine years.

The aggregate intrinsic value on the date of exercise of options exercised during the year ended June 30, 2013 was $386. No options were exercised during the fiscal year 2014. The aggregate intrinsic value of the outstanding options as of June 30, 2014 and 2013 was $8,732 and $734, respectively.